Fluorescence properties of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (m-THPC), a sensitizer used in photodynamic therapy (PDT), were studied in the presence of three native cyclodextrins (CDs) - alpha-,
beta-, and gamma-CD - and two modified cyclodextrins - heptakis (2,6-di-O-methyl) beta-CD (Me-beta-CD) and heptakis (2-O-hydroxy-propyl) beta-CD (HP-beta-CD). The CDs studied have been shown to undergo
the formation of an inclusion complex with m-THPC, leading to a large enhancement (up to 300 times) of m-THPC fluorescence intensity depending on the CD used. Stoichiometry and association constants have
been determined on the basis of the variation of fluorescence intensity. A 1:2 stoichiometry has been found for m-THPC complexes with gamma-CD, Me-beta-CD, and HP-beta-CD. Association constants as high
as K = 9.5 X 10 8 M-2 in the case of m-THPC/2Me-beta-CD and K = 2.7 X 10 9 M-2 in the case of m-THPC/2HP-beta-CD complex were determined, whereas a lower value (K = 2.4 X 10 4 M-2) was found in the case
of m-THPC/2gamma-CD. Because of the highest fluorescence enhancement (a factor of about 300) observed with Me-beta-CD, this compound would be the most suitable to improve the detection of m-THPC in further
pharmacokinetics and biodistribution studies.
The Society publishes the internationally recognized, peer reviewed journal, Applied Spectroscopy, which is available both in print and online. Subscriptions are included with membership or can be purchased by institutional or corporate organizations. Abstracts may be viewed free of charge. Previously published as Bulletin (Society for Applied Spectroscopy)